Tepmetko® (tepotinib)
for Lung Cancer

Tepmetko (tepotinib) is an oral kinase inhibitor used to treat adults with metastatic non-small cell lung cancer (NSCLC) that has an abnormal MET gene. It works by targeting the MET protein, which can drive cancer cell growth and spread when altered. By blocking MET, Tepmetko helps slow tumor growth, reduce cancer cell movement, and limit the spread of MET-dependent tumors.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lung Cancer